This on-line discussion will focus on exploring the purpose of clinical trials, the ethics and regulations for human studies, as well as the factors driving patients’ participation and their experiences in the clinical trial process. During the event, Mark Furth, FCF’s Scientific Director, will moderate a conversation with a leading researcher in immunotherapy from Johns Hopkins University, the chairperson of the Wake Forest School of Medicine Institutional Review Board (IRB) and patient/caregiver participants in previous clinical trials.
This discussion and Q&A session will be conducted as an interactive Zoom webinar and will begin at 5:30 pm Eastern time/2:30 pm Pacific time.
Panelists:
- Mark Yarchoan, MD
Asst. Professor of Oncology & clinical trial principal investigator
Johns Hopkins University - Richard Weinberg, MD
Professor of Gastroenterology & Institutional Review Board chairman
Department of Immunology
Wake Forest School of Medicine - Emily Barrett
Patient - Kurt Losert
Caregiver